StageZero Life Sciences Ltd's market cap is currently ―. The company's EPS TTM is C$-0.158; its P/E ratio is ―; StageZero Life Sciences Ltd is scheduled to report earnings on May 20, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Jun 24	Mar 24	Sep 23	Jun 23
Income Statement	-
Total Revenue	$ 499.66K	$ 390.08K	$ 521.92K	$ 745.49K	$ 793.31K
Gross Profit	$ -69.60K	$ 7.82K	$ 300.54K	$ 168.41K	$ 121.56K
EBIT	$ -352.12K	$ -604.80K	$ -345.60K	$ -795.03K	$ -366.93K
EBITDA	$ -368.85K	$ -560.99K	$ -327.32K	$ -756.93K	$ -307.35K
Net Income Common Stockholders	$ -399.28K	$ -649.46K	$ -386.35K	$ -821.88K	$ -401.54K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 15.03K	$ 20.72K	$ 5.54K	$ 189.72K	$ 64.21K
Total Assets	$ 580.75K	$ 583.74K	$ 379.47K	$ 508.42K	$ 784.49K
Total Debt	$ 1.30M	$ 1.29M	$ 1.01M	$ 662.20K	$ 815.91K
Net Debt	$ 1.29M	$ 1.26M	$ 1.00M	$ 472.48K	$ 751.70K
Total Liabilities	$ 11.71M	$ 11.32M	$ 10.58M	$ 9.58M	$ 9.20M
Stockholders Equity	$ -11.13M	$ -10.74M	$ -10.20M	$ -9.07M	$ -8.41M
Cash Flow	-
Free Cash Flow	$ 10.26K	$ -62.92K	$ -92.94K	$ 47.82K	$ 7.05K
Operating Cash Flow	$ 10.26K	$ -62.92K	$ -92.94K	$ 47.82K	$ 7.05K
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ -15.95K	$ 78.11K	$ 72.09K	$ -87.93K	$ 20.86K

Currency in USD

StageZero Life Sciences Ltd Earnings and Revenue History

Income Statement >

StageZero Life Sciences Ltd Debt to Assets

Balance Sheet >

StageZero Life Sciences Ltd Cash Flow

Cash Flow >

StageZero Life Sciences Ltd Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing